Biochips Market Size worth $ 52833.98 Million by 2027: Triton Market Research
As per Triton Market Research, the Global Biochips Market is projected to progress with 19.32% of CAGR over the forecast period of 2019-2027.
Introduction to market
The major driving factors in the global biochips market are the growth in personalized medicines, rising incidences & treatment of cancer, constant rise in worldwide healthcare spending and the increasing number of investments in biotechnology R&D. Moreover, the development in biochips technology, and the widening application areas are the key opportunities nudging growth of the market towards the projected period. However, challenges such as availability of substitute technologies, unclear regulatory guidelines and cost constraints are the factors restraining the biochips market growth.
Browse full research report with TOC on "Biochips Market Analysis By Type (DNA Chips (Drug discovery, Agricultural biotechnology, Gene expression, Drug discovery, Gene expression, Single nucleotide polymorphism (SNP) genotyping, Other DNA chips), Lab on a Chip (Drug discovery, Point of care and In vitro diagnosis, Clinical Diagnostics, Proteomics, Genomics, Other lab on a chip), Protein Chips (Proteomics, Drug discovery, High throughput screening, Diagnostics, Expression profiling, Other protein chips), Other Chips (Tissue arrays, Cell arrays), by End Users (Academic and research institute, Biotechnology and pharmaceutical companies, Hospital and diagnostics centers), by Substrate (Polymers, Glass, Silicon, Other substrate materials)) and Geography"
Request Free Sample Now: https://www.tritonmarketresearch.com/reports/biochips-market#request-free-sample
According to Triton Market research, the North America region held the largest share amongst the various regional markets
Europe, Asia-Pacific, North America, and rest of the world are the four regional segments covered in the biochips market report. North America biochips market leads the global scene by capturing the largest share in the year 2018. The market is driven by the increasing number of investments in biotechnology R&D and the increasing market demand for personalized medicine. Over the forecasted period, the Asia Pacific region will dominate the global biochips market in terms of CAGR.
The major companies operating in the Biochips Market are:
- Cepheid Inc.
- Agilent Technology Inc
- Gamida for Life Group
- Agilent Technology Inc.
- Bio-rad Laboratories Inc
- Biochain Institute Inc.
- Perkinelmer Inc.
- Illumina Inc.
- Biomerieux SA
- Samsung Electronics Inc.
- Imgenex
Find more research reports on Lifescience Industry, by Triton Market Research: